Please login to the form below

Not currently logged in
Email:
Password:

AAT deficiency

This page shows the latest AAT deficiency news and features for those working in and with pharma, biotech and healthcare.

AZ makes gene therapy move with 4DMT alliance

AZ makes gene therapy move with 4DMT alliance

treat the genetic disease alpha 1 antitrypsin (AAT) deficiency.

Latest news

  • Shire receives FDA nod for self-infusion of Glassia Shire receives FDA nod for self-infusion of Glassia

    Blaine Forshage, Shire's US immunology franchise lead, commented that patients with AAT deficiency “ are managing a challenging disorder that may require regular regimented care”. “ ... Chronically under-diagnosed, only an estimated 10% of the 100,

  • Biologics buoyant

    52 . Kamada/Baxter. Glassia (liquid Alpha-1 Antitrypsin; AAT) – AAT deficiency (US, Canada, Australia and New Zealand).

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics